Researchers evaluated insulin-like growth factor-1 serum levels after treatment with VRDN-001 in patients with thyroid eye disease.
Bill Kekevian
Bill Kekevian is the medical editor of Ophthalmology Advisor. He has served as a writer and editor covering ophthalmology and optometry for 9 years. He can be reached at [email protected]